1. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study. Issue 10080 (29th April 2017) Authors: Feagan, Brian G; Sandborn, William J; D'Haens, Geert; Panés, Julián; Kaser, Arthur; Ferrante, Marc; Louis, Edouard; Franchimont, Denis; Dewit, Olivier; Seidler, Ursula; Kim, Kyung-Jo; Neurath, Markus F; Schreiber, Stefan; Scholl, Paul; Pamulapati, Chandrasena; Lalovic, Bojan; Visvanathan, Sudha; ... Journal: Lancet Issue: Volume 389:Issue 10080(2017) Page Start: 1699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study. (October 2018) Authors: Feagan, Brian G; Panés, Julián; Ferrante, Marc; Kaser, Arthur; D'Haens, Geert R; Sandborn, William J; Louis, Edouard; Neurath, Markus F; Franchimont, Denis; Dewit, Olivier; Seidler, Ursula; Kim, Kyung-Jo; Selinger, Christian; Padula, Steven J; Herichova, Ivona; Robinson, Anne M; Wallace, Kori; Zh... Journal: Lancet gastroenterology and hepatology Issue: Volume 3:Number 10(2018) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Issue 9 (26th June 2018) Authors: Baeten, Dominique; Østergaard, Mikkel; Wei, James Cheng-Chung; Sieper, Joachim; Järvinen, Pentti; Tam, Lai-Shan; Salvarani, Carlo; Kim, Tae-Hwan; Solinger, Alan; Datsenko, Yakov; Pamulapati, Chandrasena; Visvanathan, Sudha; Hall, David B; Aslanyan, Stella; Scholl, Paul; Padula, Steven J Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 9(2018) Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗